← Back to Search

Vagus Nerve Stimulation

Vagus Nerve Stimulation + Rehabilitation for Spinal Cord Injury

N/A
Recruiting
Led By Radha Korupolu
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, post-treatment (first day after 6 week inclinic therapy), 30 days, and 90 days follow-up.

Summary

This trial uses a device that sends electrical signals to a nerve in the neck while patients do exercises. It targets adults with partial spinal cord injuries in the neck area who struggle with arm and hand movement. The electrical signals may help improve how the brain and nerves respond to exercise, aiding recovery.

Who is the study for?
This trial is for individuals at least 12 months post-traumatic cervical spinal cord injury (C8 and above), with some upper limb movement, like pinching. They must meet surgical criteria for VNS implantation. Excluded are those with non-traumatic SCI, vocal cord issues, significant brain injuries, prior vagus nerve damage, certain medications affecting neurotransmitters, other complicating conditions or surgeries, medical or mental instability, or pregnancy.
What is being tested?
The study tests the safety and effectiveness of pairing vagus nerve stimulation (VNS) with arm rehabilitation to improve upper extremity function in people with cervical spinal cord injury. Participants will receive either active VNS or a sham procedure alongside their rehabilitation exercises.
What are the potential side effects?
Potential side effects may include discomfort from the VNS device itself and typical risks associated with any surgical implantation procedure. Specific side effects related to VNS can vary but might involve changes in voice tone or involuntary throat sensations.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, post-treatment (first day after 6 week inclinic therapy), 30 days, and 90 days follow-up.
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, post-treatment (first day after 6 week inclinic therapy), 30 days, and 90 days follow-up. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Safety as assessed by number of subjects with post surgical complications
Secondary study objectives
Change in Depression as assessed by the Patient Health Questionnaire (PHQ-8)
Pain
Change in capability of using arms and hands as assessed by the Capabilities of Upper Extremity Questionnaire (CUE-Q)
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Treatment groupExperimental Treatment2 Interventions
Participants in the treatment group will receive 18 goal-directed upper extremity rehabilitation therapy sessions with paired VNS over six weeks. Followed by 90 days home exercise program.
Group II: Control GroupPlacebo Group2 Interventions
Participants in the control group will receive 18 goal-directed upper extremity rehabilitation therapy sessions with sham VNS over six weeks. Followed by 90 days home exercise program.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for spinal cord injury (SCI) include neuromodulation techniques such as Vagus Nerve Stimulation (VNS) and Transcutaneous Electrical Nerve Stimulation (TENS). VNS works by delivering electrical impulses to the vagus nerve, which can enhance neuroplasticity and improve rehabilitation outcomes by modulating the central nervous system's response to injury. TENS provides symptomatic relief by altering pain perception through continuous electrical impulses delivered via surface electrodes. These treatments are crucial for SCI patients as they can potentially improve motor function, reduce pain, and enhance overall quality of life by leveraging the body's own neural pathways to promote recovery and adaptation.
Efficacy of pulsed low-intensity electric neuromuscular stimulation in reducing pain and disability in patients with myofascial syndrome.

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
946 Previous Clinical Trials
344,281 Total Patients Enrolled
MicroTransponder Inc.Industry Sponsor
7 Previous Clinical Trials
1,336 Total Patients Enrolled
Radha KorupoluPrincipal InvestigatorThe University of Texas Health Science Center, Houston
1 Previous Clinical Trials
45 Total Patients Enrolled

Media Library

Active VNS (Vagus Nerve Stimulation) Clinical Trial Eligibility Overview. Trial Name: NCT05601661 — N/A
Broken neck Research Study Groups: Treatment group, Control Group
Broken neck Clinical Trial 2023: Active VNS Highlights & Side Effects. Trial Name: NCT05601661 — N/A
Active VNS (Vagus Nerve Stimulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05601661 — N/A
~2 spots leftby Apr 2025